CAMBRIDGE, Mass.----Idera Pharmaceuticals today announced the publication of preclinical data demonstrating that its Toll-like Receptor 9 agonist in combination with bevacizumab, the anti-vascular endothelial growth factor monoclonal antibody, resulted in co-operative anti-tumor activity in animal models of colon cancer.
5 operations you don't want to get -- and what to do instead
Maybe I'm the wrong ex-patient to be telling you this: Experimental surgery erased Stage III colon cancer from my shell-shocked body six years ago. But even I've got to admit that all is not well in America's operating rooms: At least 12,000 Americans die each year from unnecessary surgery, according to a Journal of the American Medical Association report. And tens of thousands more suffer
Experts predict colon cancer will decline in coming years
Even though the statistics have been improving in the fight against colon cancer, it remains the number two cause of death for men and women. But a recent study finds doctors and patients have what they need to dramatically reduce that risk over the next 10 to 20 years.
Surviving Colon Cancer Is Tied to Family History of It
Someone who has a parent or a sibling with colorectal cancer faces about a 1-in-10 chance of developing colon cancer, compared with 1 in 20 for those with no family history, the new study says.
Contact:
Copyright © 2005 Colon Cancer Solutions.com All Rights Reserved